Target intelligence / Profile preview

Histidinol-phosphate phosphatase (HPP)

Target
HPP
Molecular classification
Enzyme, Hydrolase, Phosphatase
01

Overview

Histidinol-phosphate phosphatase (EC 3.1.3.15) is an enzyme that catalyzes the ninth step of the histidine biosynthesis pathway, specifically the dephosphorylation of L-histidinol phosphate to L-histidinol (UniProt: P00815). This enzyme is essential for the survival of various bacteria, fungi, and plants, but it is absent in humans, who lack the entire histidine biosynthetic machinery and must obtain the amino acid through diet (PMID: 25613578). Consequently, it is a highly regarded target for the development of novel antibiotics, antifungals, and herbicides, as its inhibition leads to histidine auxotrophy and the cessation of protein synthesis (PMID: 15907911). In some organisms like Escherichia coli, the phosphatase activity is part of a bifunctional enzyme (HisB) that also possesses imidazoleglycerol-phosphate dehydratase activity, whereas in others like Saccharomyces cerevisiae, it is a monofunctional protein (PMID: 2185415). While no drugs targeting this enzyme are currently FDA-approved, research has identified several experimental inhibitors, including substrate analogs and metal-binding compounds, particularly for treating infections like tuberculosis (PMID: 25613578). A significant challenge in targeting this enzyme is the potential for pathogens to bypass the block by scavenging histidine from the host environment (PMID: 10931331).

Other names
L-histidinol-phosphate phosphohydrolaseHIS2HisBHistidinol-phosphatase
02

Mechanism of action

Inhibition of the histidine biosynthetic pathway, leading to histidine auxotrophy and cessation of protein synthesis and microbial growth.

03

Biological functions

Histidine biosynthetic processAmino acid metabolismDephosphorylation
04

Disease associations

Bacterial infectionFungal infectionTuberculosis
05

Safety considerations

Pathogen bypass via histidine scavenging from host environmentPotential off-target effects on unrelated human phosphatases
06

Interacting drugs

Experimental inhibitors (e.g., propan-2-one-1,3-diphosphonate)

2 more in the full profile.

07

Biomarkers

Intracellular histidine levelsHistidinol phosphate accumulationMicrobial growth inhibition

Beyond the preview

Go deeper on Histidinol-phosphate phosphatase (HPP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histidinol-phosphate phosphatase (HPP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call